The global biotech API manufacturing services market, valued at US$ 38.9 Billion in 2022, is projected to grow at a CAGR of 7.1% from 2023 to 2031, surpassing US$ 73 Billion by 2031. biotech API ...
New York, Feb. 08, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Pharmaceutical API Manufacturing Global Market Report 2023" - https ...
As part of the collaboration, Gland Pharma will set up a dedicated sterile API manufacturing suite at its JNPC facility in ...
Efficiency and adaptability are crucial in the ever-evolving manufacturing industry. As manufacturers adopt advanced technologies like IoT, AI, and cloud computing, the need for seamless integration ...
Manufacturers and contract development and manufacturing organizations are developing processes and facilities to meet growing specialty API demand. For decades, APIs, the foundation of the ...
China controls nearly 40% of global active pharmaceutical ingredient output, and a cascade of U.S. executive orders, tariffs, ...
HPAPI manufacturing takes more than containment—it requires a partner that can manage scale-up, tech transfer and future ...
Just weeks after announcing a deal to sell its antibiotics manufacturing in the U.S. to Neopharma, India’s Dr. Reddy’s Laboratories says it will now unload its API manufacturing business in Jeedimetla ...
China and India, which are the largest producers of APIs for the U.S. drug supply, also account for most of the FDA regulatory actions. Not only do quality problems at Chinese and Indian firms raise ...
Manufacturers in Europe and the United States have announced plans for new in-country API development and manufacturing capabilities. Manufacturers in Europe and the United States have announced plans ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results